Werke:
- The Effect of Elotuzumab on T cells in Patients with Multiple Myeloma
- Multiple myeloma long-term survivors exhibit sustained immune alterations decades after first-line therapy
- Selective elimination of immunosuppressive T cells in patients with multiple myeloma
- Cereblon-binding proteins expression levels correlate with hyperdiploidy in newly diagnosed multiple myeloma patients